Prot# MEL11: Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients with Metastatic Melanoma

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date6/1/08 → 6/1/11

Funding

  • Sanofi Pasteur Limited (MEL11)